GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, firstname.lastname@example.org
Index / Exbio / Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml / Product Detail : 1A-320-C025 Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml
#1A-320-C025 Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml
Product name : Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml
Catalog number : 1A-320-C025
Quantity: 0.025 mg
Supplier name : Exbio
Data sheet: Ask more or other datasheet now !
About this Product :Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml
ELISA Storage and handeling
The storage for all reagents of the Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml should be done at temperatures between 2 and 8 degrees Celsius. We strongly recommend you to avoid cycles of freezing and thawing in order to preserve the sensitivity of the kit.
Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml monclonal andibody monoclonal antobodies are directed against a specific epitope. The use Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml is much more reproducable than with a polyclonal antibody.
Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml immunoglobuline1 The Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml is very stable with a high affinity. IgGs is normally 65% of the total IgG of natural serum. Contact email@example.com or the chat to know the purity of this purified IgG1
Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml http://biotech-map.com/aa_search/table_sample.html?q=monoclonal&filter=
Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml is a monoclonal antibody which is greatly purified and with high binding affinity for the antigen that it is risen against. If used correctly and according the protocol, this antibody will provide excellent and reproducible results with guaranteed success for the tested and confirmed applications. Amongst the advantages of the monoclonal antibodies are: the fact that while the hybridoma takes a bit longer to be produced, once the line is ready there is virtually an endless supply of these antibodie throughout time with little to no variations in recognition sites of the antigen in different batches; in comparison to the polyclonal antibodies monoclonal antibodies are highly specific to a given epitope and can be used in applications where specific targeting is required.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Mouse Monoclonal to IgM, Clone CH2, Isotype IgG1Application WB, FC, ICC, ELISA Concentration 0.1 mg_ml
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1345: T Cell Receptor Signaling Pathway
WP1354: B Cell Receptor Signaling Pathway
WP1359: IL-3 Signaling Pathway
WP1011: T Cell Receptor Signaling Pathway
WP1025: B Cell Receptor Signaling Pathway
WP1031: IL-3 Signaling Pathway
WP107: Translation Factors
WP110: Translation Factors
WP1130: T Cell Receptor Signaling Pathway
WP1144: B Cell Receptor Signaling Pathway
WP1150: IL-3 Signaling Pathway
WP1220: Translation Factors
WP1313: Insulin Signaling
WP1315: IL-5 Signaling Pathway
WP1321: Myometrial Relaxation and Contraction Pathways
WP1323: EGFR1 Signaling Pathway
WP1333: Hypothetical Network for Drug Addiction
WP1337: MAPK signaling pathway
WP1338: Peptide GPCRs
WP1341: Kit Receptor Signaling Pathway
WP1363: p38 MAPK Signaling Pathway
WP1365: Calcium Regulation in the Cardiac Cell
WP1367: TGF-beta Receptor Signaling Pathway
WP1370: TGF Beta Signaling Pathway
WP1371: G Protein Signaling Pathways
Related Genes :
[Notch1 Motch] Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]
[Ctnnb1 Catnb] Catenin beta-1 (Beta-catenin)
[Shh Hhg1] Sonic hedgehog protein (SHH) (HHG-1) [Cleaved into: Sonic hedgehog protein N-product (Sonic hedgehog protein 19 kDa product); Sonic hedgehog protein C-product (Sonic hedgehog protein 27 kDa product)]
[Wnt5a Wnt-5a] Protein Wnt-5a
[Cacna1c Cach2 Cacn2 Cacnl1a1 Cchl1a1] Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2)
[Bcl2 Bcl-2] Apoptosis regulator Bcl-2
[Tp53 P53 Trp53] Cellular tumor antigen p53 (Tumor suppressor p53)
[Bmp4 Bmp-4 Dvr-4] Bone morphogenetic protein 4 (BMP-4) (Bone morphogenetic protein 2B) (BMP-2B)
[Sirt1 Sir2l1] NAD-dependent protein deacetylase sirtuin-1 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (SIR2alpha) (Sir2) (mSIR2a) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]
[App] Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloidogenic glycoprotein) (AG) (Beta-amyloid precursor protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (APP-C99); Beta-amyloid protein 42 (Beta-APP42); Beta-amyloid protein 40 (Beta-APP40); C83; P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (APP-C59) (Amyloid intracellular domain 59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (APP-C57) (Amyloid intracellular domain 57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AID(50)) (Gamma-CTF(50)); C31]
[Tgfb1] Transforming growth factor beta-1 (TGF-beta-1) [Cleaved into: Latency-associated peptide (LAP)]
[Mef2c] Myocyte-specific enhancer factor 2C
[Vegfa Vegf] Vascular endothelial growth factor A (VEGF-A) (Vascular permeability factor) (VPF)
[Fgfr2 Bek Ect1] Fibroblast growth factor receptor 2 (FGFR-2) (EC 126.96.36.199) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332)
[Sox9 Sox-9] Transcription factor SOX-9
[Psen1 Ad3h Psnl1] Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)]
[Hif1a] Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein)
[Akt1 Akt Rac] RAC-alpha serine/threonine-protein kinase (EC 188.8.131.52) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene)
[Ceacam1 Bgp Bgp1] Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (Biliary glycoprotein D) (MHVR1) (Murine hepatitis virus receptor) (MHV-R) (CD antigen CD66a)
[Bax] Apoptosis regulator BAX
[Cav1 Cav] Caveolin-1
[Tnf Tnfa Tnfsf2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[Abl1 Abl] Tyrosine-protein kinase ABL1 (EC 184.108.40.206) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)
[Fmr1 Fmr-1] Synaptic functional regulator FMR1 (Fragile X mental retardation protein 1 homolog) (FMRP) (Protein FMR-1) (mFmr1p)
[Gata3 Gata-3] Trans-acting T-cell-specific transcription factor GATA-3 (GATA-binding factor 3)
[Gja1 Cxn-43] Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein)
[Kit Sl] Mast/stem cell growth factor receptor Kit (SCFR) (EC 220.127.116.11) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117)
[Sirt2 Sir2l2] NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2)
[Gli3] Transcriptional activator GLI3 (GLI3 form of 190 kDa) (GLI3-190) (GLI3 full length protein) (GLI3FL) [Cleaved into: Transcriptional repressor GLI3R (GLI3 C-terminally truncated form) (GLI3 form of 83 kDa) (GLI3-83)]
[Ifitm3] Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b) (DSPA2b) (Fragilis protein) (Interferon-inducible protein 15) (Mouse ifitm-like protein 1) (Mil-1)
 Fibulin-3 in joint aging and osteoarthritis pathogenesis.
 Local Application of Probiotic Bacteria Prophylaxes against Sepsis and Death Resulting from Burn Wound Infection.
 IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation.
 Protective Effects of Quercetin on Mitochondrial Biogenesis in Experimental Traumatic Brain Injury via the Nrf2 Signaling Pathway.
 Reduced excitability and impaired nociception in peripheral unmyelinated fibers from Nav1.9-null mice.
 Circadian variation of isoniazid pharmacokinetics in mice.
 Sevoflurane protects against hepatic ischemia/reperfusion injury by modulating microRNA-200c regulation in mice.
 Platycodin D inhibits interleukin-13-induced the expression of inflammatory cytokines and mucus in nasal epithelial cells.
 Anti-oxidant, anti-inflammatory, analgesic and antipyretic activities of grapevine leaf extract (Vitis vinifera) in mice and identification of its active constituents by LC-MS/MS analyses.
 Structural characterization of a novel derivative of myricetin from Mimosa pudica as an anti-proliferative agent for the treatment of cancer.
Enter catalog number :